Oxford/AstraZeneca nasal spray COVID-19 vaccine fails first trial
Researchers at Oxford announced today that a nasal spray version of the COVID-19 vaccine theyve developed with AstraZeneca failed in early stages of clinical trials. The underwhelming results in were published in eBioMedicine.
Tuesday, October 11, 2022 at 5:00 pm